Showing results (1421-1430 of 1,459) with videos related to
Sort By:
Pageof 146
Journal of Medicinal Chemistry|January 5, 2001
Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclaseD L Selwood, D G Brummell, J Budworth, et al.Pathogens and Disease|June 16, 2022
An effective workshop on "How to be an Effective Mentor for Underrepresented STEM Trainees"Andrea G Marshall, Zer Vue, Caroline B Palavicino-Maggio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2020
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt LymphomaMark Roschewski, Kieron Dunleavy, Jeremy S Abramson, et al.Pathogens and Disease|June 17, 2022
The role of mentoring in promoting diversity equity and inclusion in STEM Education and ResearchAndrea G Marshall, Zer Vue, Caroline B Palavicino-Maggio, et al.Blood|April 25, 2012
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn-Kathrin Eisfeld, Guido Marcucci, Kati Maharry, et al.Blood|October 20, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trialNaval G Daver, Monique Dail, Jacqueline S Garcia, et al.Journal of Hematology & Oncology|May 6, 2017
Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stagesMeng Yang, Umit Topaloglu, W Jeffrey Petty, et al.Haematologica|July 15, 2021
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemiaDimitrios Papaioannou, Hatice G Ozer, Deedra Nicolet, et al.Biorxiv : the Preprint Server for Biology|November 26, 2025
Insertion of an invading retrovirus regulates a novel color trait in swordtail fishNadia B Haghani, Tristram O Dodge, John J Baczenas, et al.Clinical Lymphoma, Myeloma & Leukemia|February 20, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b TrialMarina Y Konopleva, Monique Dail, Naval G Daver, et al.Pageof 146